Blue Ocean Capital Group
蓝海资本
Blue Ocean Capital Group (蓝海资本) is a Chinese early-stage venture fund that appears in elsewhere's corpus mainly through its co-investment activity in 2021. It participated in the angel-round syndicate for Tapdata, a real-time data services startup, alongside Variable Capital (变量资本) , and followed on as a co-investor in Signet Therapeutics' (希格生科) angel-plus round led by 5Y Capital (五源资本) in October 2021 . The fund's profile beyond these two deals is thin in elsewhere's current coverage — no dedicated strategy description, AUM figure, or team details appear in the retrieved material.
AI-generated — may contain errors, please verify.
Coverage
November: Foresight and Boundless Imagination | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Signet Therapeutics Raises Nearly $10 Million to Power AI-Enabled Innovative Targeted Drug Development Through Disease Modeling Platform
Advancing pharmaceutical innovation in China.
五源资本·5Y News | "Tapdata Secures Tens of Millions of USD Across Two Consecutive Rounds, Carving Out a New Track in Real-Time Data Services"
Building a real-time data service platform for TP operations.
五源资本·
